---
figid: PMC9673652__JAH3-11-e026097-g001
pmcid: PMC9673652
image_filename: JAH3-11-e026097-g001.jpg
figure_link: /pmc/articles/PMC9673652/figure/jah37593-fig-0001/
number: Figure 1
figure_title: Pathway for myocarditis after COVID‐19 vaccine
caption: BID indicates twice a day; BNP, brain natriuretic peptide; CMP, comprehensive
  metabolic panel; COVID, coronavirus disease; CRP, C‐reactive protein; EBV, Epstein–Barr
  virus; ED, emergency department; ESR, erythrocyte sedimentation rate; IVIG, intravenous
  immunoglobulin; LV, left ventricle; LVEF, left ventricular ejection fraction; MIS‐C,
  multisystem inflammatory syndrome in children; MRI, magnetic resonance imaging;
  PCR, polymerase chain reaction; and XR, x‐ray.
article_title: 'Myocarditis After COVID‐19 Vaccination in Pediatrics: A Proposed Pathway
  for Triage and Treatment.'
citation: Nefthi Sandeep, et al. J Am Heart Assoc. 2022 Nov 1;11(21):e026097.
year: '2022'

doi: 10.1161/JAHA.122.026097
journal_title: 'Journal of the American Heart Association: Cardiovascular and Cerebrovascular
  Disease'
journal_nlm_ta: J Am Heart Assoc
publisher_name: John Wiley and Sons Inc.

keywords:
- COVID‐19 vaccine
- myocarditis
- pathway
- pediatric
- Inflammatory Heart Disease
- Pericardial Disease
- Pediatrics
- Magnetic Resonance Imaging (MRI)
- Diagnostic Testing

---
